ESP 2014 Final Programme - page 83

83
ECP 2014 ·
London
Poster Presentations
a
Sunday
Sunday, 31 Aug
PS-03
092
TTF-1 positive breast cancer: A cautionary
tale
Peter Ellery,
United Kingdom
N. Archard, A. Saetta, M. Gandy, M. Falzon
093
MicroRNA-21 detected in breast cancer
tissue and cells by a new electrochemical
magnetobiosensor: A rapid, sensitive,
accurate and unexpensive alternative to
other molecular approaches
Rosario Granados,
Spain
S. Campuzano, R. Torrente Rodríguez,
E. López Hernández, F. Conzuelo,
J. J. Domínguez, J. M. Jover,
J. M. Sánchez Puelles, J. M. Pingarrón
094
Evaluation of Ki67 as a useful routine
marker in breast cancer
Priya Bhagwat,
United Kingdom
M. Ally, J. Moorehead
095
High Axl expression is associated with
markers of poor prognosis in African
breast cancer
Lavina Ahmed,
Norway
H. Nalwoga, D. R. Micklem, J. B. Arnes,
H. Wabinga, L. A. Akslen
096
Sensitivity and specificity of needle core
biopsies for the diagnosis of phyllodes
tumours: Twelve years experience at a ter-
tiary referral centre
Sarah Aitken,
United Kingdom
E. Provenzano, M. Jimenez-Linan,
B. Mahler-Araujo, P. Wright, V. Broecker
097
Myxofibrosarcoma/myxoid malignant fi-
brous histiocytoma: A rare primary breast
sarcoma
Argiro-Ioanna Ieronimaki,
Greece
A. Tsavari, K. Koulia, E. Arkoumani,
D. Myoteri, T. Vasilakaki, K. Manoloudaki
098
Rosai-Dorfman Disease of the breast: MRI
findings with pathological correlation
Luiza Moore,
United Kingdom
P. Britton, G. Follows, P. Wright
099
Neuroendocrine Carcinoma (NEC) of the
breast clinicopathological study of 90 NEC
cases in conjunction with 1522 non-NEC
cases
Tomonori Kawasaki,
Japan
M. Suzuki, T. Kosaka, R. Sugimoto, Y. Mue,
N. Uesugi, K. Ishida, R. Katoh, T. Sugai,
A. Sapino
100
Metastases to the breast from gastric car-
cinoma: IPO Coimbra experience in eight
years
Marcos Guimarães,
Portugal
P. Figueiredo
101
Copy number abberations of oncogenes
and tumour-supressor genes in breast
cancer
George Frank,
Russia
N. Danilova, A. Petrov, L. Zavalishina,
A. Matsionis, Y. Andreeva
102
Immunochistochemical characteristics of
triple negative breast cancer subtypes
Natalia Danilova,
Russia
G. Frank, N. Nefedova, P. Malkov,
L. Zavalishina, M. Gorelik, Y. Andreeva
103
ESR1 gene amplification is absent in
breast cancer, but ESR1 gene gain is asso-
ciated with luminal B group (subgroup
with high Ki67 index): A multiplex liga-
tion-dependent probe amplification study
of 55 cases
Alexandr Matcionis,
Russia
L. Zavalishina, A. Petrov, I. Pavlenko,
N. Danilova
104
Evaluation of Her2/Top2A gene amplifica-
tion and chromosome 17 centromere gain
in different molecular subtypes of breast
cancer
Alexandr Matcionis,
Russia
I. Pavlenko, A. Petrov
105
Invasive paget disease of the breast: A
case report of an unrecognized entity
Helen Trichia,
Greece
G. Mitropoulou, A.-I. Ieronimaki, O. Tzaida,
E. Paliouri, K. Kalogerakos
1...,73,74,75,76,77,78,79,80,81,82 84,85,86,87,88,89,90,91,92,93,...216
Powered by FlippingBook